DE69637181D1 - Vorrichtung zur inaktivierung von viralen kontaminationen in blutprodukten - Google Patents

Vorrichtung zur inaktivierung von viralen kontaminationen in blutprodukten

Info

Publication number
DE69637181D1
DE69637181D1 DE69637181T DE69637181T DE69637181D1 DE 69637181 D1 DE69637181 D1 DE 69637181D1 DE 69637181 T DE69637181 T DE 69637181T DE 69637181 T DE69637181 T DE 69637181T DE 69637181 D1 DE69637181 D1 DE 69637181D1
Authority
DE
Germany
Prior art keywords
blood products
viral contamination
inactivating viral
blood
inactivating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69637181T
Other languages
English (en)
Other versions
DE69637181T2 (de
Inventor
Ruth Laub
Wael Luc De
Giambattista Mario Di
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sartorius Stedim Biotech GmbH
Original Assignee
CAF DCF CVBA SCRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/BE1995/000069 external-priority patent/WO1996002571A1/fr
Application filed by CAF DCF CVBA SCRL filed Critical CAF DCF CVBA SCRL
Application granted granted Critical
Publication of DE69637181D1 publication Critical patent/DE69637181D1/de
Publication of DE69637181T2 publication Critical patent/DE69637181T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3623—Means for actively controlling temperature of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
    • A61M2205/053—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy ultraviolet
DE69637181T 1995-07-14 1996-07-15 Vorrichtung zur inaktivierung von viralen verunreinigungen in blutprodukten Expired - Lifetime DE69637181T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
WOPCT/BE95/00069 1995-07-14
PCT/BE1995/000069 WO1996002571A1 (fr) 1994-07-14 1995-07-14 Concentre de fibrinogene issu de plasma sanguin, procede et installation pour sa preparation
PCT/BE1996/000076 WO1997003706A1 (fr) 1995-07-14 1996-07-15 Procede et installation d'inactivation de contaminants presents dans des produits sanguins

Publications (2)

Publication Number Publication Date
DE69637181D1 true DE69637181D1 (de) 2007-09-06
DE69637181T2 DE69637181T2 (de) 2008-04-17

Family

ID=3888743

Family Applications (3)

Application Number Title Priority Date Filing Date
DE29624488U Expired - Lifetime DE29624488U1 (de) 1995-07-14 1996-07-15 Anlage zur Inaktivierung von in Blutprodukten enthaltenen Kontaminierungen
DE69637181T Expired - Lifetime DE69637181T2 (de) 1995-07-14 1996-07-15 Vorrichtung zur inaktivierung von viralen verunreinigungen in blutprodukten
DE0000840624T Pending DE96923791T1 (de) 1995-07-14 1996-07-15 Verfahren und vorrichtung zur inaktivierung von verunreinigungen in blutprodukten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE29624488U Expired - Lifetime DE29624488U1 (de) 1995-07-14 1996-07-15 Anlage zur Inaktivierung von in Blutprodukten enthaltenen Kontaminierungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE0000840624T Pending DE96923791T1 (de) 1995-07-14 1996-07-15 Verfahren und vorrichtung zur inaktivierung von verunreinigungen in blutprodukten

Country Status (9)

Country Link
US (2) US6190608B1 (de)
EP (2) EP0840624B1 (de)
JP (2) JPH11509210A (de)
AT (1) ATE367830T1 (de)
CA (1) CA2225470C (de)
DE (3) DE29624488U1 (de)
DK (1) DK0840624T3 (de)
ES (1) ES2290957T3 (de)
WO (1) WO1997003706A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0840624B1 (de) * 1995-07-14 2007-07-25 CAF - DCF cvba - scrl Vorrichtung zur inaktivierung von viralen kontaminationen in blutprodukten
GB9821342D0 (en) 1998-10-02 1998-11-25 Common Services Agency Device for treatment of biological fluids
US6970740B2 (en) * 2000-04-19 2005-11-29 Clemson University UVC rediation therapy for leukemia
WO2001080939A2 (en) 2000-04-19 2001-11-01 Clemson University Uvc radiation therapy for chronic lymphocytic leukemia
DE10031851B4 (de) * 2000-07-04 2005-10-13 Blutspendedienst der Landesverbände des Deutschen Roten Kreuzes Niedersachsen, Sachsen-Anhalt, Thüringen, Oldenburg und Bremen gGmbH Photodynamische Behandlung und UV-B-Bestrahlung einer Thrombozyten-Suspension
DE10056096A1 (de) 2000-11-13 2002-06-13 Bayer Ag Vorrichtung zur Bestrahlung von Flüssigkeiten
US7381976B2 (en) * 2001-03-13 2008-06-03 Triton Thalassic Technologies, Inc. Monochromatic fluid treatment systems
US20030060747A1 (en) * 2001-05-17 2003-03-27 Fries William M. Fluid flow path for a fluid treatment system using light for the decontamination of fluid products
US20030030011A1 (en) * 2001-05-17 2003-02-13 Purepulse Technologies, Inc. Light treatment control in a fluid treatment system using light for the treatment of fluid products
DE10152159A1 (de) * 2001-10-25 2003-05-15 Aventis Behring Gmbh Verfahren zur proteinschonenden Reinigung von kontaminierten biologischen Flüssigkeiten
CA2481144A1 (en) * 2002-04-12 2003-10-23 Throwleigh Technologies, L.L.C. Methods and apparatus for decontaminating fluids
AU2003259514A1 (en) * 2002-08-30 2004-03-19 Globalmed Technologies De Colombia S.A. Apparatus and method for treating infectious diseases
KR101119448B1 (ko) * 2002-09-11 2012-03-15 추가이 세이야쿠 가부시키가이샤 단백질 정제 방법
EP1415669A1 (de) * 2002-09-19 2004-05-06 Aventis Behring GmbH Sterilisationsverfahren für Protein enthaltende biologische Zusammensetzungen
EP1400248A1 (de) * 2002-09-19 2004-03-24 Aventis Behring GmbH Sterilisationsprozess für Proteine enthaltende biologische Zubereitungen
ATE540702T1 (de) 2003-02-27 2012-01-15 Baxter Int Verfahren für die überprüfbare inaktivierung von pathogenen in einem biologischen fluid durch bestrahlung
US7553938B2 (en) 2004-02-27 2009-06-30 Octapharma Ag Method of providing a purified, virus safe antibody preparation
DE102005062410A1 (de) * 2005-12-23 2007-08-09 Forschungsgemeinschaft Der Drk-Blutspendedienste E.V. Verfahren zur Bestrahlung von Thrombozytenkonzentraten in flexiblen Behältnissen mit ultraviolettem Licht
DE102005062634A1 (de) * 2005-12-23 2007-06-28 Blutspendedienst der Landesverbände des Deutschen Roten Kreuzes Niedersachsen, Sachsen-Anhalt, Thüringen, Oldenburg und Bremen gGmbH Verfahren zur Inaktivierung von Pathogenen in Spenderblut, Blutplasma oder Erythrozytenkonzentraten in flexiblen Behältnissen unter Bewegung
US20090274576A1 (en) * 2006-01-18 2009-11-05 Barry Ressler System and method for container sterilization using UV light source
DE102006008125A1 (de) 2006-02-20 2007-09-06 Bayer Technology Services Gmbh Reinigbare Wendelmodule
EP1902740A1 (de) * 2006-09-19 2008-03-26 Maco Pharma S.A. Blutbeutelsystem und Verfahren, um Pathogene in Blutplättchenkonzentraten mit Hilfe des Blutbeutelsystems zu neutralisieren
EP2008669A1 (de) 2007-06-22 2008-12-31 Maco Pharma S.A. Bestrahlungsvorrichtung zur Deaktivierung von Krankheitserregern und/oder Leukozyten in einer biologischen Flüssigkeit und entsprechendes Verfahren
US8125333B2 (en) * 2008-06-04 2012-02-28 Triton Thalassic Technologies, Inc. Methods, systems and apparatus for monochromatic UV light sterilization
FR2941866B1 (fr) * 2009-02-09 2011-05-13 Maco Pharma Sa Procede pour modifier les proprietes d'un fluide par irradiation et systeme pour sa mise en oeuvre
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
CN104436171A (zh) * 2014-12-25 2015-03-25 华兰生物工程股份有限公司 一种制备人纤维蛋白原制剂的方法及其制备的制剂
KR101923569B1 (ko) * 2017-01-12 2018-11-29 비클시스템주식회사 유브이씨 엘이디를 이용한 광면역치료기
CN111317841A (zh) * 2020-03-04 2020-06-23 上海朝惠环保科技有限公司 一种自动化消毒系统及消毒控制方法
WO2023017153A1 (en) 2021-08-13 2023-02-16 Biotest Ag Fibrinogen compositions and methods of preparation

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3926556A (en) * 1973-05-30 1975-12-16 Raymond Marcel Gut Boucher Biocidal electromagnetic synergistic process
US3894236A (en) * 1973-12-10 1975-07-08 Wayne K Hazelrigg Device for irradiating fluids
DE2916711A1 (de) 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
GB8630102D0 (en) * 1986-12-17 1987-01-28 Gunn A Blood processing device
DE3734923C1 (de) * 1987-10-15 1989-01-26 Biotest Pharma Gmbh Verfahren zur Herstellung einer sterilen Plasmaproteinloesung,die Fibrinogen und den Gerinnungsfaktor XIII enthaelt
GB8807380D0 (en) * 1988-03-29 1988-05-05 Gunn A Blood processing apparatus
DE3824647A1 (de) * 1988-07-20 1990-02-01 Wedeco Entkeimungsanlagen Vorrichtung zur bestrahlung von medien mittels uv-licht
US5024766A (en) * 1988-11-09 1991-06-18 Shahzad Mahmud Point of use deionized water purification unit
DE4005488A1 (de) * 1990-02-21 1991-08-22 Wabner Dietrich Verfahren und vorrichtung zur wasserentgiftung
JP2968086B2 (ja) * 1990-08-28 1999-10-25 古野電気株式会社 水溶性切削油の嫌臭気除去装置
EP0653911B1 (de) 1992-08-07 2000-05-17 Cerus Corporation Verfahren zur inaktivierung von bakterien in blutpräparaten mit hilfe von methoxypsoralen
JPH06279297A (ja) * 1993-03-25 1994-10-04 Asahi Chem Ind Co Ltd ウィルス感染性除去方法およびその装置
ATE301186T1 (de) * 1993-05-28 2005-08-15 New York Blood Ct Inc Verfahren zur sterilisation biologischer zusammensetzungen und das dabei erhaltene produkt
CA2165065A1 (en) 1993-06-23 1995-01-05 Henrietta Margolis-Nunno System for viral inactivation of blood
JPH07196531A (ja) * 1993-12-28 1995-08-01 Chemo Sero Therapeut Res Inst 血液凝固因子の感染性夾雑ウイルス不活化法
WO1996002571A1 (fr) 1994-07-14 1996-02-01 Croix-Rouge De Belgique Concentre de fibrinogene issu de plasma sanguin, procede et installation pour sa preparation
EP0840624B1 (de) * 1995-07-14 2007-07-25 CAF - DCF cvba - scrl Vorrichtung zur inaktivierung von viralen kontaminationen in blutprodukten
GB9821342D0 (en) * 1998-10-02 1998-11-25 Common Services Agency Device for treatment of biological fluids
EP1833530A2 (de) * 2004-11-22 2007-09-19 Energex Systems, Inc. Blutbestrahlungssystem, relevante vorrichtungen und verfahren zur bestrahlung von blut

Also Published As

Publication number Publication date
US6833108B2 (en) 2004-12-21
US20010046450A1 (en) 2001-11-29
DK0840624T3 (da) 2007-11-05
CA2225470A1 (en) 1997-02-06
JPH11509210A (ja) 1999-08-17
WO1997003706A1 (fr) 1997-02-06
DE69637181T2 (de) 2008-04-17
EP0840624B1 (de) 2007-07-25
EP1842561A1 (de) 2007-10-10
ATE367830T1 (de) 2007-08-15
DE96923791T1 (de) 2004-07-08
EP0840624A1 (de) 1998-05-13
US6190608B1 (en) 2001-02-20
JP2009077707A (ja) 2009-04-16
CA2225470C (en) 2010-06-29
DE29624488U1 (de) 2004-04-15
ES2290957T3 (es) 2008-02-16

Similar Documents

Publication Publication Date Title
DE69637181D1 (de) Vorrichtung zur inaktivierung von viralen kontaminationen in blutprodukten
DE69621161D1 (de) Verfahren und zusammensetzungen zur selektiven modifikation von nukleinsaeuren
ATE73663T1 (de) Phosphonylmethoxyalkyl-adeninen zur behandlung von viruskrankheiten.
DE3789158D1 (de) Verfahren zur Sterilisation und Vorrichtung dafür.
DE69525473T2 (de) Vorrichtung zur behandlung von blutgefässen
DE59600309D1 (de) Vorrichtung zur Behandlung von Flüssigkeiten, insbesondere von Blut
DK0429570T3 (da) Osteoinducerende præparater
DE59003825D1 (de) Vorrichtung zur Erzeugung von Ozon.
DE69011854T2 (de) Vorrichtung zur Sterilisierung eines Druckluftstromes mit Hilfe von Ultraviolettstrahlung.
DE69003695T2 (de) Verfahren zur Lichtvulkanisation von zur Lichtvulkanisation verwendbaren Dentalharzen und Vorrichtung dafür.
DE69421196D1 (de) Vorrichtung zur behandlung von überbiss
ATE164065T1 (de) Neues verfahren zur behandlung von depression
ATE165345T1 (de) Sulfonsaeurederivate zur behandlung von viruserkrankungen
DE69509843D1 (de) Apparat zur Behandlung z.B. von Poststücken
ATE81976T1 (de) 2-pyrimidinyl-1-piperazin-derivate zur behandlung von alkoholismus.
DE69233622D1 (de) Vorrichtung zur Erzeugung von Ansagen
ATE194648T1 (de) Verfahren zur inaktivierung von viren in präparationen von proteinen
DE29518530U1 (de) Vorrichtung zur Behandlung von Abluft
DE3873744T2 (de) Vorrichtung and verfahren zur sterilisation.
FI903143A0 (fi) Menetelmä ihmisen nuhaviruksen serotyypittämiseksi
DE59010230D1 (de) Verfahren zur Sterilisation von chirurgischem Material
DE58907891D1 (de) Verfahren zur Sterilisation von intraocularen Linsen.
DE3851196D1 (de) Vorrichtung zur laserbehandlung von gewebe.
DE29505038U1 (de) Vorrichtung zur Behandlung von Atemluft
EP0866654A4 (de) Methode für die behandlung einer hepatitisvirusinfektion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SARTORIUS STEDIM BIOTECH GMBH, 37079 GOETTINGE, DE